← Back to news

G

Google Business, RSS Feed

Eric Jackson on the “radical change” and “big swings” coming from Opendoor’s new management - Sherwood News

China accuses Nvidia of violating anti-monopoly laws - BBC

Trump endorses dramatic shift to the US economy - CNN

How JPMorgan traders see the Fed decision this week going down and market reaction - CNBC

Tesla jumps after Musk acquires EV maker's shares worth $1 billion - Reuters

PayPal Ushers in a New Era of Peer-to-Peer Payments, Reimagining How Money Moves to Anyone, Anywhere - PayPal Newsroom

Fed Governor Lisa Cook claimed 2nd residence as "vacation home" in loan estimate, potentially undercutting Trump fraud claims - CBS News

Nvidia Broke Antitrust Law, China Says, as Tensions With U.S. Mount - The New York Times

Trump calls for 'bigger' interest rate cut ahead of Fed meeting - Reuters

Paramount-Warner Deal Could Unlock Billions in Synergies, Says Top Analyst - TipRanks

Trump advocates that companies stop reporting earnings on a quarterly basis - CNBC

‘Load Up,’ Says 5-Star Analyst on Micron Stock (MU) Ahead of Q4 Earnings - TipRanks

Tesla Stock Soars. Why Elon Musk Is a ‘Wartime’ CEO. - Barron's

Donald Trump calls on US companies to ditch quarterly reporting - Financial Times

Stock Market Today: Dow, Nasdaq Gain Amid Trump-China Talks; Tesla Surges On Musk Buy (Live Coverage) - Investor's Business Daily

Dow Jones Futures Rise: Tesla Soars On Elon Musk Stock Move; Nvidia Falls On China News - Investor's Business Daily

Oracle’s AI Surge Boosts Stock but $300 Billion OpenAI Deal Raises Risk - TipRanks

Social Security increase is coming: Latest COLA estimate and when you’ll know the amount - AL.com

5 Things to Know Before the Stock Market Opens - Investopedia

Robinhood Unveils a Publicly Traded Venture Capital Fund - The New York Times

aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis - GlobeNewswire

52.6% Steroid-Free: aTyr's Efzofitimod Shows Promise in Largest-Ever Sarcoidosis Trial Despite Miss - Stock Titan

Stocks and dollar hold firm at start of action-packed week - Reuters

China says preliminary probe shows Nvidia violated anti-monopoly law - Reuters

Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - Yahoo Finance

Here’s what the data says people ask ChatGPT - The Washington Post

The dot-com era’s highest-profile analyst says there will be a big AI bust - MarketWatch

The FBI Destroyed an Internet Weapon, but Criminals Picked Up the Pieces - The Wall Street Journal

China’s economic woes deepen, new data shows - Semafor

Fed’s Powell Faces a Power Struggle. Why the Outcome Is Key for Stock Markets and 5 More Things to Know Today. - Barron's

Starlink outage knocks tens of thousands offline worldwide - theregister.com

Wall Street ticks toward another record as Tesla vrooms higher - AP News

Elon Musk Purchases About $1 Billion Worth of Tesla Shares - Bloomberg.com

Long-term unemployment at post-pandemic high, straining workers and economy - The Washington Post

Morning Bid: Fed week begins - Reuters

Tesla shares gain after Elon Musk reveals $1 billion stock buy - CNBC

Why Prediction Markets Like Kalshi Are Attracting Savvy Billionaire Investors - Forbes

We set out to craft the perfect phishing scam. Major AI chatbots were happy to help. - Reuters

Wall Street Strategists See Stock Rally Stalling on Fed Rate Cut - Bloomberg.com

Bank of America sees nearly $1 trillion market cap potential for gold miners - KITCO

The Fed faces economic uncertainty and political pressure as it decides whether to cut rates - AP News

Nebius Stock To $450? - Forbes

Gold Hasn’t Rallied This Much Since 1979 - Yahoo Finance

China says Nvidia violated anti-monopoly laws, significantly escalating trade tensions with US - CNN

Why is Sam Altman losing sleep? OpenAI CEO addresses controversies in sweeping interview - CNBC

The Fed Tried to Avoid a Fight With Trump. It Got One Anyway. - The New York Times

China says Nvidia violated antitrust law for Mellanox acquisition - Financial Times

Novo Nordisk Stock (NVO) Rises After Triple-Dose Trial Hits 19% Weight Loss - TipRanks

Russia revives barter trade to dodge Western sanctions - Reuters